Research
Evidence reviews across every form sermorelin is sold in — injections, tablets and troches, and nasal sprays. No secondary summaries: every claim traced to the trial, the label, or the paper of record.
Every published price, lowest first
Ranked on the standing month-to-month rate — the only number that survives contact with month two, and the one sellers advertise least.
Head-to-head comparisons
Two sellers side by side on price, dose disclosure, format and states served — scored on the same rubric.
6 articles
- Evidence
Sermorelin Before and After: What the Trials Actually Show
Nobody has ever run a trial that photographed a sermorelin before/after. Here is the real data: one adult trial, sex-split results, and what changed for whom over five months.
8 min read - Safety
Sermorelin Side Effects: The Real Data, Including Cancer
What the actual sermorelin trials reported for side effects, what the cancer question really shows in the research, and what has never been studied at all.
8 min read - Formats
Sermorelin Dosage: What Studies Used vs. What Is Sold
The actual doses used in sermorelin trials, how they compare to what sellers market, and why nobody has tested a “bodybuilding dose” in a controlled study.
8 min read - Formats
What Is Sermorelin? Mechanism, Uses, and Its Catch
Sermorelin does not add growth hormone to your body — it asks your pituitary to make more. Here is exactly how that works, what it is used for, and the one condition that has to be true for it to work at all.
7 min read - Safety
Is Sermorelin FDA-Approved? The Real Answer
Sermorelin was FDA-approved once, under a different name, and that approval is gone. What is sold today is compounded — which is legal, but not the same thing as approved.
8 min read - Evidence
Does sermorelin work? What the trials actually measured
Sermorelin reliably makes your pituitary release growth hormone. Beyond that the evidence is one placebo-controlled trial in 19 adults from 1997 — lean body mass up in men only, nothing in women, and no effect on sleep in either.
9 min read